2020 Survey Report
A new report from the Drug Enforcement and Policy Center (DEPC) indicates continued dissatisfaction with the Ohio Medical Marijuana Control Program (OMMCP), primarily based on pricing. The report builds on a previous, first-of-its-kind survey conducted in 2019 by DEPC and Harm Reduction Ohio.
This research aims to fill in a critical gap in our understanding of the OMMCP. With future marijuana reforms on the horizon, the perceived effectiveness and success of the current system among patients and potential patients may shape the long-term future of the program.
- 61.6% of respondents reported being “extremely” or “somewhat dissatisfied” with the OMMCP. This is a slight decrease from 67% in 2019. However, the degree of dissatisfaction decreased significantly. 30.2% reported extreme dissatisfaction in this year’s survey compared with 48% in 2019.
- Two main reasons cited for not using medical marijuana: cost and a fear of losing employment.
- 51.5% of respondents with a qualifying condition reported that they currently use marijuana.
- 84.2% of respondents indicated preference for purchasing marijuana from a legal dispensary if marijuana was made fully legal and product was similarly priced to the unregulated market.
- 52.8% of people who reported a qualifying condition and to be currently using marijuana have received a doctor’s recommendation under the OMMCP.
DEPC revised this report on October 6, 2020. Read and download the full report on SSRN.
Marijuana pricing in the Ohio Medical Marijuana Control Program
Upon the release of Ohio Medical Marijuana Control Program at Two Years: Evaluating Satisfaction and Perception, the Drug Enforcement and Policy Center received questions from multiple entities regarding the pricing table on page 13. The table compared marijuana pricing in Ohio medical dispensaries with pricing on Ohio’s illicit market and dispensaries in the state of Michigan. Upon further examination, we determined that the pricing information included in the original report is inaccurate. It has since been revised and a new version has been uploaded to SSRN. In response to this revision, we have produced an addendum that explains the original calculation and provides revised figures based on additional data obtained from the Ohio Department of Commerce (ODOC). All data used in this document is reported in a detailed chart at the end of the addendum.
Determining the “average price” of a marijuana product based on publicly available data is difficult and it is especially difficult to compare “average prices” across states. We are grateful for inquiries about out report and the opportunity to provide additional and updated information. We recommend, for the benefit of both patients and researchers, that the Ohio Medical Marijuana Control Program (OMMCP) publicly report information about pricing for both flower and manufactured products.
Email Holly Griffin, Public Engagement Specialist, Drug Enforcement and Policy Center, at firstname.lastname@example.org.
2019 Survey Report
Read the report from the preliminary 2019 online survey conducted by DEPC and Harm Reduction Ohio.